Clinical study on the correlation between the changes of endocrine hormone levels and ocular surface related index in children and the therapeutic effect of rhGH

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100042864

Enrollment

Unknown

Registered

2021-01-30

Start date

2021-01-27

Completion date

Unknown

Last updated

2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Child endocrine diseases

Interventions

obesity group, short stature group, hypothyroidism group and healthy control group:Nil

Eligibility

Sex/Gender

All

Age

5 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Subjects are grouped according to disease; 2. They re divided into obesity group, short stature group, hypothyroidism group and healthy control group.

Exclusion criteria

Exclusion criteria: 1. Patients with primary hypothalamic and pituitary diseases; 2. Children with chromosomal abnormalities; 3. Children with severe infection, systemic diseases and other chronic wasting diseases; 4. Children who have used drugs that may affect endocrine hormone secretion, glucose and lipid metabolism and body composition.

Design outcomes

Primary

Measure	Time frame
IGF-1;	—

Countries

China

Contacts

Public ContactShuang Liang

The Second Hospital of Shandong University

liangshuang3508@163.com+86 17660082768

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026